Ascletis Pharma Shares Gain After Covid-19 Drug Approved for Clinical Trial
By Clarence Leong Shares of Ascletis Pharma Inc. rose sharply in Hong Kong, after the Chinese drugmaker said it received regulatory approval for a clinical trial of its Covid-19 drug candidate. Hangzhou-based Ascletis…